Furthermore, ANOVA tests on the tumor‐enriched clusters revealed that CD8‐c09‐Isg15, CD8‐c10‐Cd244, CD8‐c11‐Ccr7, CD8‐c12‐Gzmc, CD4‐c09‐Gzmb, Macro‐c03‐Ifit3, and NK‐c03‐Ccl5 were impacted by combined effects of liver tumors and anti‐PD‐1 treatment (Figure 5G). The gene discussed is CCL5; the disease is neoplasm.